Active Ingredient: ALPELISIB
Proprietary Name: VIJOICE
Dosage Form; Route of Administration: GRANULES; ORAL
Strength: 50MG/PACKET
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218466
Product Number: 001
Approval Date: Apr 24, 2024
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information